132687-04-8

11-(2-fluoroethyl)-6-methyl-6,11-dihydro-5H-pyrido[2,3-b][1,5]benzodiazepin-5-one

11-(2-fluoroethyl)-6-methyl-6,11-dihydro-5H-pyrido[2,3-b][1,5]benzodiazepin-5-one

Catalog No.1859719
Name 11-(2-fluoroethyl)-6-methyl-6,11-dihydro-5H-pyrido[2,3-b][1,5]benzodiazepin-5-one
CAS132687-04-8
FormulaC15H14FN3O

Request a Quote

Structure of 132687-04-8

About 11-(2-fluoroethyl)-6-methyl-6,11-dihydro-5H-pyrido[2,3-b][1,5]benzodiazepin-5-one

11-(2-fluoroethyl)-6-methyl-6,11-dihydro-5H-pyrido[2,3-b][1,5]benzodiazepin-5-one is a chemical compound registered under CAS number 132687-04-8, with the molecular formula C15H14FN3O and a molecular weight of about 271.28 g/mol. KingPharm Group supplies 11-(2-fluoroethyl)-6-methyl-6,11-dihydro-5H-pyrido[2,3-b][1,5]benzodiazepin-5-one for laboratory research and bulk production; product code 1859719. Send an inquiry for purity, packaging, price and lead time.

CAS Number
132687-04-8
Molecular Formula
C15H14FN3O
Molecular Weight
271.28 g/mol

Related Products

  1. Urea, N,N'-bis[2-[(2-thienylthio)methyl]-3-furanyl]-
    139308-24-0
  2. 4-fluoro-5-hydroxyindolin-2-one
    948553-68-2
  3. Phenol, 4,4'-(9H-fluoren-9-ylidene)bis[2,6-dibromo-
    94854-03-2
  4. n-Hexanonacontane
    7763-13-5
  5. Sulfamic acid, N-(trans-1,4-dimethylcyclohexyl)-, 2,2,2-trichloroethylester
    926906-07-2
  6. Cyclohexanone, 3-chloro-5-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, (5R)-
    199613-51-9
  7. 1,2,4-Benzotriazin-3-amine, 7-phenoxy-, 1-oxide
  8. Benzeneacetic acid, a-[[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]methyl]-4-hydroxy
  9. Boronic Acid, B-[3-(4-Morpholinyl)-2-Pyridinyl]-
  10. 1,3,4,5-tetrahydrothiopyrano[4,3-b]indole-8-carboxylic Acid
  11. 132687-04-8 msds
  12. CAS No 132687-04-8 supplier
  13. CASNo 132687-04-8 distributor
  14. CAS # 132687-04-8 manufacturer
  15. CAS Number 132687-04-8 safety
  16. CAS RN 132687-04-8 wholesale
  17. 2026-10-29 Find 11-(2-fluoroethyl)-6-methyl-6,11-dihydro-5H-pyrido[2,3-b][1,5]benzodiazepin-5-one,CAS No.132687-04-8,Formula:C15H14FN3O in KingPharm Group